Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
108,529,588
-
Share change
-
-3,347,540
-
Total reported value
-
$307,146,439
-
Put/Call ratio
-
43%
-
Price per share
-
$2.83
-
Number of holders
-
119
-
Value change
-
-$14,905,284
-
Number of buys
-
59
-
Number of sells
-
49
Institutional Holders of ACHILLION PHARMACEUTICALS IN - COM (ACHN) as of Q2 2018
As of 30 Jun 2018,
ACHILLION PHARMACEUTICALS IN - COM (ACHN) was held by
119 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
108,529,588 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, BlackRock Inc., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, GOLDMAN SACHS GROUP INC, CITADEL ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, ARMISTICE CAPITAL, LLC, and EcoR1 Capital, LLC.
This page lists
119
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.